Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15121757rdf:typepubmed:Citationlld:pubmed
pubmed-article:15121757lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:15121757lifeskim:mentionsumls-concept:C0348013lld:lifeskim
pubmed-article:15121757lifeskim:mentionsumls-concept:C0441723lld:lifeskim
pubmed-article:15121757lifeskim:mentionsumls-concept:C1305855lld:lifeskim
pubmed-article:15121757lifeskim:mentionsumls-concept:C0574032lld:lifeskim
pubmed-article:15121757lifeskim:mentionsumls-concept:C0078257lld:lifeskim
pubmed-article:15121757lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:15121757pubmed:issue4lld:pubmed
pubmed-article:15121757pubmed:dateCreated2004-5-3lld:pubmed
pubmed-article:15121757pubmed:abstractTextVinorelbine is currently one of the most active chemotherapeutic agents. However, it is also a moderate vesicant that is well known to cause venous irritation and phlebitis. We conducted this study to identify clinical risk factors related to the incidence of venous irritation caused by peripheral vinorelbine infusion.lld:pubmed
pubmed-article:15121757pubmed:languageenglld:pubmed
pubmed-article:15121757pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15121757pubmed:citationSubsetIMlld:pubmed
pubmed-article:15121757pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15121757pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15121757pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15121757pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15121757pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15121757pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15121757pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15121757pubmed:statusMEDLINElld:pubmed
pubmed-article:15121757pubmed:monthAprlld:pubmed
pubmed-article:15121757pubmed:issn0368-2811lld:pubmed
pubmed-article:15121757pubmed:authorpubmed-author:NishiwakiYuta...lld:pubmed
pubmed-article:15121757pubmed:authorpubmed-author:NihoSeijiSlld:pubmed
pubmed-article:15121757pubmed:authorpubmed-author:KakinumaRyuta...lld:pubmed
pubmed-article:15121757pubmed:authorpubmed-author:KubotaKaoruKlld:pubmed
pubmed-article:15121757pubmed:authorpubmed-author:OhmatsuHirono...lld:pubmed
pubmed-article:15121757pubmed:authorpubmed-author:GotoKoichiKlld:pubmed
pubmed-article:15121757pubmed:authorpubmed-author:YohKiyotakaKlld:pubmed
pubmed-article:15121757pubmed:issnTypePrintlld:pubmed
pubmed-article:15121757pubmed:volume34lld:pubmed
pubmed-article:15121757pubmed:ownerNLMlld:pubmed
pubmed-article:15121757pubmed:authorsCompleteYlld:pubmed
pubmed-article:15121757pubmed:pagination206-9lld:pubmed
pubmed-article:15121757pubmed:dateRevised2006-4-24lld:pubmed
pubmed-article:15121757pubmed:meshHeadingpubmed-meshheading:15121757...lld:pubmed
pubmed-article:15121757pubmed:meshHeadingpubmed-meshheading:15121757...lld:pubmed
pubmed-article:15121757pubmed:meshHeadingpubmed-meshheading:15121757...lld:pubmed
pubmed-article:15121757pubmed:meshHeadingpubmed-meshheading:15121757...lld:pubmed
pubmed-article:15121757pubmed:meshHeadingpubmed-meshheading:15121757...lld:pubmed
pubmed-article:15121757pubmed:meshHeadingpubmed-meshheading:15121757...lld:pubmed
pubmed-article:15121757pubmed:meshHeadingpubmed-meshheading:15121757...lld:pubmed
pubmed-article:15121757pubmed:meshHeadingpubmed-meshheading:15121757...lld:pubmed
pubmed-article:15121757pubmed:meshHeadingpubmed-meshheading:15121757...lld:pubmed
pubmed-article:15121757pubmed:meshHeadingpubmed-meshheading:15121757...lld:pubmed
pubmed-article:15121757pubmed:meshHeadingpubmed-meshheading:15121757...lld:pubmed
pubmed-article:15121757pubmed:meshHeadingpubmed-meshheading:15121757...lld:pubmed
pubmed-article:15121757pubmed:meshHeadingpubmed-meshheading:15121757...lld:pubmed
pubmed-article:15121757pubmed:meshHeadingpubmed-meshheading:15121757...lld:pubmed
pubmed-article:15121757pubmed:meshHeadingpubmed-meshheading:15121757...lld:pubmed
pubmed-article:15121757pubmed:meshHeadingpubmed-meshheading:15121757...lld:pubmed
pubmed-article:15121757pubmed:meshHeadingpubmed-meshheading:15121757...lld:pubmed
pubmed-article:15121757pubmed:meshHeadingpubmed-meshheading:15121757...lld:pubmed
pubmed-article:15121757pubmed:meshHeadingpubmed-meshheading:15121757...lld:pubmed
pubmed-article:15121757pubmed:meshHeadingpubmed-meshheading:15121757...lld:pubmed
pubmed-article:15121757pubmed:year2004lld:pubmed
pubmed-article:15121757pubmed:articleTitleHigh body mass index correlates with increased risk of venous irritation by vinorelbine infusion.lld:pubmed
pubmed-article:15121757pubmed:affiliationDivision of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan. kyoh@east.ncc.go.jplld:pubmed
pubmed-article:15121757pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15121757lld:pubmed